Skip to main content
Premium Trial:

Request an Annual Quote

XDx Drops IPO Plans

NEW YORK (GenomeWeb News) – Molecular diagnostics firm XDx has informed the US Securities and Exchange Commission that it is withdrawing its registration statement for an initial public offering.
 
The Brisbane, Calif.-based firm filed for the IPO in October 2007. At the time, the company did not say how many shares it would offer or how much money it expected to raise in the offering. It had expected to use the funds generated by the offering to expand infrastructure, propel R&D to support current and future tests, increase sales, marketing, and research staff, and expand facilities, as well as potential acquisitions.
 
XDx cited “current public market conditions” as the reason for its decision to withdraw the IPO.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.